High risk factors for valvular heart disease from dopamine agonists in patients with Parkinson’s disease

2008 ◽  
Vol 116 (2) ◽  
pp. 171-178 ◽  
Author(s):  
Tomoko Oeda ◽  
Motoko Masaki ◽  
Kenji Yamamoto ◽  
Eiji Mizuta ◽  
Naoyuki Kitagawa ◽  
...  
Keyword(s):  
Risk Factors ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Heart Disease ◽  
High Risk ◽  
Valvular Heart Disease ◽  
Dopamine Agonists ◽  
High Risk Factors

Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists

2006 ◽  
Vol 21 (8) ◽  
pp. 1261-1264 ◽  
Author(s):  
Ji-Youn Kim ◽  
Eun Joo Chung ◽  
Seung Woo Park ◽  
Won Yong Lee
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Heart Disease ◽  
Valvular Heart Disease ◽  
Dopamine Agonists ◽  
Ergot Derivative

Dopamine agonists and valvular heart disease in Japanese patients with Parkinson's disease

2007 ◽  
Vol 254 (S4) ◽  
pp. IV54-IV57 ◽  
Author(s):  
Masahiro Nagai ◽  
Noriko Nishikawa ◽  
Hayato Yabe ◽  
Hiroyoko Moritoyo ◽  
Takashi Moritoyo ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Heart Disease ◽  
Valvular Heart Disease ◽  
Dopamine Agonists ◽  
Japanese Patients

Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: A reader-blinded monocenter echocardiography study

2007 ◽  
Vol 22 (2) ◽  
pp. 234-237 ◽  
Author(s):  
Susann Junghanns ◽  
Joerg T. Fuhrmann ◽  
Gregor Simonis ◽  
Christian Oelwein ◽  
Rainer Koch ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Heart Disease ◽  
Valvular Heart Disease ◽  
Dopamine Agonists
Sign in / Sign up

Export Citation Format

Share Document